194 related articles for article (PubMed ID: 23930211)
1. Breast cancer molecular subtypes and survival in a hospital-based sample in Puerto Rico.
Ortiz AP; Frías O; Pérez J; Cabanillas F; Martínez L; Sánchez C; Capó-Ramos DE; González-Keelan C; Mora E; Suárez E
Cancer Med; 2013 Jun; 2(3):343-50. PubMed ID: 23930211
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of breast and ovarian cancer subtypes in Hispanic populations from Puerto Rico.
Rodriguez-Velazquez A; Velez R; Lafontaine JC; Colon-Echevarria CB; Lamboy-Caraballo RD; Ramirez I; Mendoza A; Casbas-Hernandez P; Armaiz-Pena GN
BMC Cancer; 2018 Nov; 18(1):1177. PubMed ID: 30482165
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological Characteristics and Breast Cancer-Specific Survival of Patients With Single Hormone Receptor-Positive Breast Cancer.
Li Y; Yang D; Yin X; Zhang X; Huang J; Wu Y; Wang M; Yi Z; Li H; Li H; Ren G
JAMA Netw Open; 2020 Jan; 3(1):e1918160. PubMed ID: 31899528
[TBL] [Abstract][Full Text] [Related]
4. Reproductive factors and subtypes of breast cancer defined by estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2: a register-based study from Korea.
Lee JS; Oh M; ;
Clin Breast Cancer; 2014 Dec; 14(6):426-34. PubMed ID: 25034438
[TBL] [Abstract][Full Text] [Related]
5. A cumulative index of exposure to endogenous estrogens and breast cancer by molecular subtypes in northern Mexican women.
Rojas-Lima E; Gamboa-Loira B; Cebrián ME; Rothenberg SJ; López-Carrillo L
Breast Cancer Res Treat; 2020 Apr; 180(3):791-800. PubMed ID: 32086656
[TBL] [Abstract][Full Text] [Related]
6. Impact of triple negative phenotype on breast cancer prognosis.
Kaplan HG; Malmgren JA
Breast J; 2008; 14(5):456-63. PubMed ID: 18657139
[TBL] [Abstract][Full Text] [Related]
7. Association between common risk factors and molecular subtypes in breast cancer patients.
Turkoz FP; Solak M; Petekkaya I; Keskin O; Kertmen N; Sarici F; Arik Z; Babacan T; Ozisik Y; Altundag K
Breast; 2013 Jun; 22(3):344-50. PubMed ID: 22981738
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological factors associated to HER-2 status in a hospital-based sample of breast cancer patients in Puerto Rico.
Ortiz AP; Frías O; González-Keelan C; Suárez E; Capó D; Pérez J; Cabanillas F; Mora E
P R Health Sci J; 2010 Sep; 29(3):265-71. PubMed ID: 20799514
[TBL] [Abstract][Full Text] [Related]
9. Body weight and risk of molecular breast cancer subtypes among postmenopausal Mediterranean women.
Crispo A; Montella M; Buono G; Grimaldi M; D'Aiuto M; Capasso I; Esposito E; Amore A; Nocerino F; Augustin LS; Giudice A; Di Bonito M; Giuliano M; Forestieri V; De Laurentiis M; Rinaldo M; Ciliberto G; De Placido S; Arpino G
Curr Res Transl Med; 2016; 64(1):15-20. PubMed ID: 27140595
[TBL] [Abstract][Full Text] [Related]
10. Survival time and molecular subtypes of breast cancer after radiotherapy in Thailand.
Kongsiang A; Tangvoraphonkchai V; Jirapornkul C; Promthet S; Kamsa-Ard S; Suwanrungruang K
Asian Pac J Cancer Prev; 2014; 15(23):10505-8. PubMed ID: 25556500
[TBL] [Abstract][Full Text] [Related]
11. [Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes].
Zhang HM; Zhang BN; Xuan LX; Zhao P
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):447-51. PubMed ID: 19950556
[TBL] [Abstract][Full Text] [Related]
12. [Breast cancer with triple-negative phenotype in the Russian patient population. Clinical and morphologic features].
Zhukova LG
Vopr Onkol; 2015; 61(2):189-94. PubMed ID: 26087596
[TBL] [Abstract][Full Text] [Related]
13. [Clinical features and prognosis analysis of different breast cancer molecular subtypes].
Yang Q; Chen J; Li HJ; Yu M; Tian CX; Lü Q
Zhonghua Zhong Liu Za Zhi; 2011 Jan; 33(1):42-6. PubMed ID: 21575463
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer in young women: have the prognostic implications of breast cancer subtypes changed over time?
Sheridan W; Scott T; Caroline S; Yvonne Z; Vanessa B; David V; Karen G; Stephen C
Breast Cancer Res Treat; 2014 Oct; 147(3):617-29. PubMed ID: 25209005
[TBL] [Abstract][Full Text] [Related]
15. Comparisons of p53, KI67 and BRCA1 expressions in patients with different molecular subtypes of breast cancer and their relationships with pathology and prognosis.
Li Y; Zhang X; Qiu J; Pang T; Huang L; Zeng Q
J BUON; 2019; 24(6):2361-2368. PubMed ID: 31983107
[TBL] [Abstract][Full Text] [Related]
16. Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014.
Schroeder MC; Rastogi P; Geyer CE; Miller LD; Thomas A
Oncologist; 2018 Apr; 23(4):481-488. PubMed ID: 29330212
[TBL] [Abstract][Full Text] [Related]
17. Breast Cancer Survival Analysis Based on Immunohistochemistry Subtypes (ER/PR/HER2): a Retrospective Cohort Study.
Poorolajal J; Nafissi N; Akbari ME; Mahjub H; Esmailnasab N; Babaee E
Arch Iran Med; 2016 Oct; 19(10):680-686. PubMed ID: 27743431
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of young age (<35 years) by subtype based on ER, PR, and HER2 status in breast cancer: a nationwide registry-based study.
Kim EK; Noh WC; Han W; Noh DY
World J Surg; 2011 Jun; 35(6):1244-53. PubMed ID: 21472372
[TBL] [Abstract][Full Text] [Related]
19. Associations between sociodemographic and clinicopathological factors and breast cancer subtypes in a population-based study.
Llanos AA; Chandwani S; Bandera EV; Hirshfield KM; Lin Y; Ambrosone CB; Demissie K
Cancer Causes Control; 2015 Dec; 26(12):1737-50. PubMed ID: 26376894
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer risk factors in relation to molecular subtypes in breast cancer patients from Kenya.
Sayed S; Fan S; Moloo Z; Wasike R; Bird P; Saleh M; Shaikh AJ; Figueroa JD; Naidoo R; Makokha FW; Gardner K; Oigara R; Njoroge FW; Magangane P; Mutebi M; Chauhan R; Mwanzi S; Govender D; Yang XR
Breast Cancer Res; 2021 Jun; 23(1):68. PubMed ID: 34174935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
